TOPRA announces new board to lead the organisation into its second decade

At its Annual Review Meeting on 27th November, TOPRA announced the new Board of Directors appointed after a well-supported election process.

The new Board will be:

PRESIDENT

Jonathan Trethowan

Past-President

Patrizia Nestby

Related content:

Human medicines highlights - Issue 56 - October 2013

The October 2013 issue of the European Medicines Agency's newsletter 'Human medicines highlights' is now available.

All issues of the newsletter are available on the Agency's website.

Related content:

Veterinary medicines inch towards a single market

A single European market for veterinary medicines is unlikely to be in place before 2017, delegates heard at the TOPRA Veterinary Symposium in Lisbon, organised in conjunction with Direcção-Geral de Alimentação e Veterinária (DGAV).

Related content:

Further detailed discussion ahead for draft EU Clinical Trials Regulation

The earliest vote on the proposed Clinical Trial Regulation has now been deferred until March 2014 – a necessary delay as stakeholders have drilled down into the detail of the proposals intending to streamline medicines development in the EU as speakers at the TOPRA Annual Symposium in Lisbon, Portugal, explained to an audience of around 400 regulatory professionals.

Related content:

More regulatory oversight for medical devices comes into force

Increased regulatory oversight of Notified Bodies (NBs) came into force this week (15 October), delegates were told at the TOPRA Annual Medical Devices Symposium held in Lisbon, in conjunction with the Portuguese Agency Infarmed.

Related content: